We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$335M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$140M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$82.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.4M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNOA icon
4326
Sonoma Pharmaceuticals
SNOA
$6.56M
$9.18K ﹤0.01%
429
– –
DBE icon
4327
Invesco DB Energy Fund
DBE
$91.6M
$9.17K ﹤0.01%
463
+362
+358% +$7.21K
FORR icon
4328
Forrester Research
FORR
$225M
$9.16K ﹤0.01%
315
-445
-59% -$13.2K
PNTG icon
4329
Pennant Group
PNTG
$1.33B
$9.14K ﹤0.01%
744
-709
-49% -$9.02K
CMAX
4330
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$9.13K ﹤0.01%
98
-54
-36% -$4.76K
BOAC.U
4331
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
$9.11K ﹤0.01%
912
– –
EZRA
4332
Reliance Global Group
EZRA
$1.94M
$9.1K ﹤0.01%
3
-2
-40% -$5.4K
FRGE
4333
DELISTED
Forge Global Holdings
FRGE
$9.08K ﹤0.01%
+249
New +$6.1K
CGNT icon
4334
Cognyte Software
CGNT
$692M
$9.06K ﹤0.01%
1,488
+1,157
+350% +$5.38K
NCSM icon
4335
NCS Multistage Holdings
NCSM
$135M
$9.06K ﹤0.01%
533
-655
-55% -$12.7K
PBFS icon
4336
Pioneer Bancorp
PBFS
$428M
$9.06K ﹤0.01%
1,012
+59
+6% +$517
WKHS icon
4337
Workhorse Group
WKHS
$34.1M
$9.06K ﹤0.01%
3
– –
DOMH icon
4338
Dominari Holdings
DOMH
$71M
$9.05K ﹤0.01%
3,109
-349
-10% -$1.05K
DLPN icon
4339
Dolphin Entertainment
DLPN
$14.2M
$9.04K ﹤0.01%
2,630
-148
-5% -$584
DEM icon
4340
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.96B
$9.03K ﹤0.01%
236
+21
+10% +$807
WINT
4341
DELISTED
Windtree Therapeutics
WINT
$9.03K ﹤0.01%
8
+7
+700% +$14.2K
AKBA icon
4342
Akebia Therapeutics
AKBA
$240M
$9.03K ﹤0.01%
9,869
-13,027
-57% -$12.6K
DSP icon
4343
Viant Technology
DSP
$264M
$9.03K ﹤0.01%
1,958
-749
-28% -$3.32K
UGL icon
4344
ProShares Ultra Gold
UGL
$801M
$9.03K ﹤0.01%
620
+84
+16% +$1.31K
ACAHU
4345
DELISTED
Atlantic Coastal Acquisition Corp. Unit
ACAHU
$9.02K ﹤0.01%
851
-41
-5% -$417
CRIS icon
4346
Curis
CRIS
$4.5M
$9.02K ﹤0.01%
27
-2
-7% -$651
GTI
4347
DELISTED
Graphjet Technology
GTI
$9.01K ﹤0.01%
14
– –
WMC
4348
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$9K ﹤0.01%
1,015
-529
-34% -$4.59K
AE
4349
DELISTED
Adams Resources & Energy Inc
AE
$9K ﹤0.01%
256
+33
+15% +$1.19K
TRDA icon
4350
Entrada Therapeutics
TRDA
$274M
$8.99K ﹤0.01%
594
-698
-54% -$9.62K
172 173
174
175 176

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.